Steris (NYSE: STE)
Q1 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 2.020 | 2.040 | 0.0200 | ||||
REV | 1.190B | 1.211B | 21.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Steris (NYSE: STE) through any online brokerage.
Other companies in Steris’s space includes: Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).
The latest price target for Steris (NYSE: STE) was reported by Needham on Friday, May 13, 2022. The analyst firm set a price target for 248.00 expecting STE to rise to within 12 months (a possible 17.36% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Steris (NYSE: STE) is $211.32 last updated July 1, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.43 per share of Class A Common Stock. The quarterly cash dividend was payable on June 28, 2022 to stockholders of record on June 13, 2022.
Steris’s Q1 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Steris.
Steris is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.